Daliao Psychiatric Nursing Home, Kaohsiung Municipal Kai-Syuan Psychiatric Hospital
Kaohsiung City, Taiwan
NCT Number: NCT07781007
This study aims to evaluate the effects of a scaffolding-based board game intervention on cognitive and functional outcomes in older adults with schizophrenia living in psychiatric nursing homes. Participants will be assigned by clusters to either an intervention group or a control group. The intervention group will receive a 12-week board game training program, while the control group will receive usual care. Cognitive and functional outcomes will be assessed before the intervention, immediately after the 12-week intervention, and three months after the intervention. The study will examine whether the board game intervention can improve cognitive and daily functioning in older adults with schizophrenia.
Trial opening soon.
Get Notified55 year and older
All sexes
Interventional
Not applicable
Kaohsiung City, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive a scaffolding-based board game intervention once weekly for 12 weeks, with each session lasting approximately 60 minutes.
Time frame: Baseline, immediately after the 12-week intervention, and 3 months after completion of the intervention
Contact information is provided by the study sponsor or research team.
Kaohsiung Kai-Suan Psychiatric Hospital
Other Gov
Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia Living in Psychiatric Nursing Homes: A Cluster-Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07788755
Cognition Disorders, Cognitive Dysfunction
Minneapolis, Minnesota, United States
View Trial DetailsNCT07781748
Behavior, Behavioral Symptoms
Chengdu, Sichuan, China
View Trial DetailsNCT07772349
Mental Disorders, Schizophrenia
Houston, Texas, United States
View Trial DetailsNCT07767526
Antipsychotic Drug, Constipation
Shanghai, China
View Trial Details